Evidence map›Paper›PMID 27264178›Full record

ArticleCell reports2016

CEACAM1-Mediated Inhibition of Virus Production.

Alon Vitenshtein, Yiska Weisblum, Sebastian Hauka, Anne Halenius, Esther Oiknine-Djian, Pinchas Tsukerman, Yoav Bauman, Yotam Bar-On, Noam Stern-Ginossar, Jonatan Enk and 10 more

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 23 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. CEACAM1 in Liver Injury, Metabolic and Immune Regulation.International journal of molecular sciences · 2018
    Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 11 institutions in 4 countries.

Alon VitenshteinThe Lautenberg Center for General and Tumor Immunology, The BioMedical Research Institute Israel Canada of the Faculty of Medicine (IMRIC), The Hebrew University Hadassah Medical School, 91120 Jerusalem, Israel.
Yiska WeisblumDepartment of Clinical Microbiology and Infectious Diseases, Hadassah University Hospital, 91120 Jerusalem, Israel.
Sebastian HaukaInstitute for Virology, Heinrich-Heine-University, 40225 Düsseldorf, Germany.
Anne HaleniusInstitute of Virology, Medical Center, University of Freiburg, 79104 Freiburg, Germany.
Esther Oiknine-DjianDepartment of Clinical Microbiology and Infectious Diseases, Hadassah University Hospital, 91120 Jerusalem, Israel.
Pinchas TsukermanThe Lautenberg Center for General and Tumor Immunology, The BioMedical Research Institute Israel Canada of the Faculty of Medicine (IMRIC), The Hebrew University Hadassah Medical School, 91120 Jerusalem, Israel.
Yoav BaumanThe Lautenberg Center for General and Tumor Immunology, The BioMedical Research Institute Israel Canada of the Faculty of Medicine (IMRIC), The Hebrew University Hadassah Medical School, 91120 Jerusalem, Israel.
Yotam Bar-OnThe Lautenberg Center for General and Tumor Immunology, The BioMedical Research Institute Israel Canada of the Faculty of Medicine (IMRIC), The Hebrew University Hadassah Medical School, 91120 Jerusalem, Israel.
Noam Stern-GinossarThe Lautenberg Center for General and Tumor Immunology, The BioMedical Research Institute Israel Canada of the Faculty of Medicine (IMRIC), The Hebrew University Hadassah Medical School, 91120 Jerusalem, Israel.
Jonatan EnkThe Lautenberg Center for General and Tumor Immunology, The BioMedical Research Institute Israel Canada of the Faculty of Medicine (IMRIC), The Hebrew University Hadassah Medical School, 91120 Jerusalem, Israel.
Rona OrtenbergElla Institute of Melanoma, Cancer Research Center Sheba Medical Center, 5262000 Tel Hashomer, Israel; Department of Clinical Microbiology and Immunology, Sackler Faculty of Medicine, Tel Aviv University, 6997801 Tel Aviv, Israel.
Julie TaiThe Lautenberg Center for General and Tumor Immunology, The BioMedical Research Institute Israel Canada of the Faculty of Medicine (IMRIC), The Hebrew University Hadassah Medical School, 91120 Jerusalem, Israel.
Gal MarkelElla Institute of Melanoma, Cancer Research Center Sheba Medical Center, 5262000 Tel Hashomer, Israel; Department of Clinical Microbiology and Immunology, Sackler Faculty of Medicine, Tel Aviv University, 6997801 Tel Aviv, Israel.
Richard S BlumbergGastroenterology Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Hartmut HengelInstitute of Virology, Medical Center, University of Freiburg, 79104 Freiburg, Germany.
Stipan JonjicDepartment of Histology and Embryology and Center for Proteomics, Faculty of Medicine, University of Rijeka, HR-51000 Rijeka, Croatia.
Dana G WolfDepartment of Clinical Microbiology and Infectious Diseases, Hadassah University Hospital, 91120 Jerusalem, Israel.
Heiko AdlerHelmholtz Zentrum München, German Research Center for Environmental Health (GmbH), Research Unit Gene Vectors, 81377 Munich, Germany.
Robert KammererInstitute of Immunology, Friedrich Loeffler Institute, Federal Research Institute for Animal Health, 17493 Greifswald-Insel Riems, Germany.
Ofer MandelboimThe Lautenberg Center for General and Tumor Immunology, The BioMedical Research Institute Israel Canada of the Faculty of Medicine (IMRIC), The Hebrew University Hadassah Medical School, 91120 Jerusalem, Israel. Electronic address: oferm@ekmd.huji.ac.il.
Hebrew University of Jerusalem · ILHadassah Academic College · ILBrigham and Women's Hospital · USFriedrich-Loeffler-Institut · DEHeinrich Heine University Düsseldorf · DEHelmholtz Zentrum München · DESheba Medical Center · ILTel Aviv University · ILUniversity Medical Center Freiburg · DEUniversity of Freiburg · DEUniversity of Rijeka · HR

Funding

STRUCTURE-FUNCTION RELATIONSHIPS IN THE ALIMENTARY TRACTP30DK034854 · NIDDK · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI WAYNE I LENCER · 1986 to 2026
$32.4M
European Research Council 320473NIDDK NIH HHS P30 DK034854
6 · The paper itself

Abstract

Cells in our body can induce hundreds of antiviral genes following virus sensing, many of which remain largely uncharacterized. CEACAM1 has been previously shown to be induced by various innate systems; however, the reason for such tight integration to innate sensing systems was not apparent. Here, we show that CEACAM1 is induced following detection of HCMV and influenza viruses by their respective DNA and RNA innate sensors, IFI16 and RIG-I. This induction is mediated by IRF3, which bound to an ISRE element present in the human, but not mouse, CEACAM1 promoter. Furthermore, we demonstrate that, upon induction, CEACAM1 suppresses both HCMV and influenza viruses in an SHP2-dependent process and achieves this broad antiviral efficacy by suppressing mTOR-mediated protein biosynthesis. Finally, we show that CEACAM1 also inhibits viral spread in ex vivo human decidua organ culture.

Indexed as

AnimalsAntigens, CDCell Adhesion MoleculesCytomegalovirusCytomegalovirus InfectionsDEAD Box Protein 58DNA, ViralHumansInfluenza, HumanInterferon Regulatory Factor-3MiceOrgan Culture TechniquesOrthomyxoviridaeProtein BiosynthesisReceptors, ImmunologicTOR Serine-Threonine KinasesAntigens, CDCD66 antigensCell Adhesion MoleculesDEAD Box Protein 58DNA, ViralInterferon Regulatory Factor-3IRF3 protein, humanReceptors, ImmunologicRIGI protein, humanTOR Serine-Threonine Kinases

Identifiers

PMID27264178
PMCPMC4914772
OpenAlexW2408924604

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.